SCHEMBL3227547

SCHEMBL3227547

CC(C(=O)O)c1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 12/20 0.60
THRA P10827 9/20 0.60
PCNA P12004 6/20 0.60
LMNA P02545 4/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
ABCB11 O95342 2/20 0.60
GABRA1 P14867 2/20 0.60
PPARG P37231 2/20 0.60
GABRA2 P47869 2/20 0.60
GABRB2 P47870 2/20 0.60
CYP2D6 P10635 1/20 0.60
TSHR P16473 1/20 0.60
GABRP O00591 1/20 0.60
GABRD O14764 1/20 0.60
F2 P00734 1/20 0.60
GABRB1 P18505 1/20 0.60
GABRG2 P18507 1/20 0.60
GABRB3 P28472 1/20 0.60
ADORA1 P30542 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5861511 0.88 THRB (0.52) THRBTHRAPCNALMNAMEN1
SCHEMBL1525945 0.85 THRB (0.58) THRBTHRAPCNALMNAMEN1
SCHEMBL28303182 0.83 AKR1C3 (0.54) THRBTHRAPCNALMNACYP2D6
SCHEMBL8729396 0.83 THRB (0.62) THRBTHRAPCNALMNAMEN1
SCHEMBL5488854 0.80 AKR1C3 (0.47) MEN1KMT2ATSHRCYP1A2CYP2C9
SCHEMBL3222206 0.80 THRB (0.73) THRBTHRAPCNALMNAMEN1
SCHEMBL9748136 0.78 THRB (0.67) THRBTHRAPCNALMNAMEN1
SCHEMBL14485262 0.77 THRB (0.62) THRBTHRAPCNALMNAMEN1
SCHEMBL7086473 0.77 THRB (0.61) THRBTHRAPCNALMNAMEN1
SCHEMBL7116655 0.76 THRB (0.47) THRBTHRAPCNALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040234592-A1 Mixture containing thyroid hormone , ethanolamine and emulsifier KARO BIO AB (SE) 2004-11-25 US claimed
EP-1404413-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2004-04-07 EP claimed
EP-1398024-A2 Uses for thyroid hormone compounds KARO BIO AB (SE) 2004-03-17 EP claimed
EP-0831769-B1 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KAROBIO AB (SE) 2003-10-15 EP claimed
EP-1328265-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2003-07-23 EP claimed
WO-2002089917-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2002-11-14 WO claimed
US-20020123521-A1 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds KOO, CATHERINE, DR 2002-09-05 US claimed
US-6380255-B1 TOPICALLY APPLYING TO SKIN THYROID HORMONE COMPOUND TOGETHER WITH A BASE FOR THERAPY OF SKIN ATROPHY KARO BIO AB (SE) 2002-04-30 US claimed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 WO claimed
US-6221911-B1 REDUCING SUBCUTANEOUS FAT DEPOSITS IN A SUBJECT; IMPROVING THE SKIN CONDITION OF A SUBJECT KARO BIO AB (SE) 2001-04-24 US claimed
EP-0831769-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1998-04-01 EP claimed
WO-1996040048-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1996-12-19 WO claimed
US-20100047332-A1 Treatments for burns using thyroid hormone compound in a human KOO, CATHERINE, DR 2010-02-25 US disclosed
EP-0831769-B2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS LAVIN DR THOMAS N (US) 2008-07-23 EP disclosed
WO-2007002036-A1 TYROID HORMONE IN BURN AND ADIPOSE DEPOSITES LAVIN THOMAS (US) 2007-01-04 WO disclosed
US-20060292194-A1 Treatment for burns and adipose deposits using thyroid hormone compound in a human KOO, CATHERINE, DR 2006-12-28 US disclosed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 WO disclosed
US-6221911-B1 REDUCING SUBCUTANEOUS FAT DEPOSITS IN A SUBJECT; IMPROVING THE SKIN CONDITION OF A SUBJECT KARO BIO AB (SE) 2001-04-24 US disclosed
EP-0831769-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1998-04-01 EP disclosed
WO-1996040048-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1996-12-19 WO disclosed